Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Avid Bioservices $143.8 million exchangeable senior notes offering
We advised the initial purchasers on the Rule 144A offering
Jounce Therapeutics $64.7 million follow-on offering
We advised the underwriters on the equity offering
Owens & Minor $500 million notes offering
We advised the initial purchasers on the high-yield notes offering
Nurix Therapeutics $160.4 million follow-on offering
We advised the underwriters on the equity offering
Oscar Health $200 million revolving credit facility
We advised the administrative agent in connection with the facility
PerkinElmer $800 million notes offering
We advised the joint bookrunners on the investment-grade debt offering
Bristol Myers Squibb debt tender offer
We advised the dealer managers on a debt tender offer
Heska $175 million follow-on offering
We advised the joint book-running managers and underwriters on the equity offering
Cigna $4.3 billion senior notes offering
We advised the underwriters on the investment-grade debt offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering